Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FRG | Ann: Quarterly Portfolio Holdings as at 31 July 2024 | 30/09/24 | 0 | 86 | |||
|
|||||||
FRG | Ann: Annual Report 30 June 2024 | 25/09/24 | 0 | 85 | |||
|
|||||||
FRG | Ann: Applications, Redemptions, Units on Issue and OTC 31.8.2024 | 09:21 | 0 | 118 | |||
|
|||||||
FRG | Ann: Applications, Redemptions, Units on Issue and OTC 31.7.2024 | 07/08/24 | 0 | 122 | |||
|
|||||||
FRG | Ann: Quarterly Correlation Report - June 2024 | 15/07/24 | 0 | 80 | |||
|
|||||||
FRG | Ann: Applications, Redemptions, Units on Issue and OTC 30.6.2024 | 04/07/24 | 0 | 122 | |||
|
|||||||
FRG | Ann: DRP price announcement for the month ended 30 June 2024 | 02/07/24 | 0 | 123 | |||
|
|||||||
FRG | Ann: Final Dividend Details 30 June 2024 | 28/06/24 | 0 | 99 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |